CSIMarket
 


Atricure Inc   (ATRC)
Other Ticker:  
 
 

ATRC's Operating Income Growth by Quarter and Year

Atricure Inc 's Operating Income results by quarter and year




ATRC Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December -8.67 -4.14 -12.50 -17.50
III Quarter September -8.09 -10.72 98.67 -3.99
II Quarter June -4.14 -13.66 -15.08 -7.29
I Quarter March -5.78 -14.15 -15.89 -15.45
FY   -26.68 -42.67 55.20 -44.23



ATRC Operating Income fourth quarter 2023 Y/Y Growth Comment
Atricure Inc in the fourth quarter 2023 recorded Operating Loss of $ -8.67 millions.

According to the results reported in the fourth quarter 2023, Atricure Inc achieved the best Operating Income growth in Medical Equipment & Supplies industry. While Atricure Inc ' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


ATRC Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atricure Inc 's fourth quarter 2023 Operating Income $ -8.67 millions ATRC's Income Statement
Atricure Inc 's fourth quarter 2022 Operating Income $ -4.14 millions Quarterly ATRC's Income Statement
New: More ATRC's historic Operating Income Growth >>


ATRC Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Atricure Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRC's IV. Quarter Q/Q Operating Income Comment
IV. Quarter 2023 Operating Loss of -8.67 millions by Atricure Inc look even more unfavourable considering the Operating Loss -8.09 millions in the third quarter.

Within Medical Equipment & Supplies industry Atricure Inc achieved highest sequential Operating Income growth. While Atricure Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRC's IV. Quarter Q/Q Operating Income Comment
IV. Quarter 2023 results of -8.67 millions by Atricure Inc appear even more unfavourable considering the -8.09 millions in the third quarter.

Within Medical Equipment & Supplies industry Atricure Inc achieved highest sequential Operating Income growth. While Atricure Inc 's Operating Income growth quarter on quarter, overall rank is .


Atricure Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Operating Income 12 Months Ending $ -26.68 $ -22.15 $ -24.79 $ -34.30 $ -42.67
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Atricure Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Atricure Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ATRC's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ATRC's Competitors
Operating Income Growth for Atricure Inc 's Suppliers
Operating Income Growth for ATRC's Customers

You may also want to know
ATRC's Annual Growth Rates ATRC's Profitability Ratios ATRC's Asset Turnover Ratio ATRC's Dividend Growth
ATRC's Roe ATRC's Valuation Ratios ATRC's Financial Strength Ratios ATRC's Dividend Payout Ratio
ATRC's Roa ATRC's Inventory Turnover Ratio ATRC's Growth Rates ATRC's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2023
Incyte Corporation167.17%$ 167.174 millions
National Healthcare Corp122.32%$ 122.320 millions
Kamada Ltd 122.07%$ 122.065 millions
Astrazeneca Plc118.07%$ 118.073 millions
Vericel Corporation109.22%$ 109.219 millions
Quest Diagnostics Inc97.78%$ 97.778 millions
3m Company96.68%$ 96.677 millions
Elite Pharmaceuticals Inc 80.32%$ 80.320 millions
Dr Reddy s Laboratories Limited78.66%$ 78.663 millions
Electromed Inc 77.63%$ 77.630 millions
Eli Lilly And Company74.93%$ 74.935 millions
Dexcom Inc 72.97%$ 72.967 millions
Sotera Health Company72.89%$ 72.889 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com